WHO Warns of Widespread Resistance to Common Antibiotics Worldwide
A new WHO report warns that antibiotic resistance is rising globally, with one in six bacterial infections in 2023 resistant to treatment. Drug-resistant Gram-negative bacteria, including E. coli and K. pneumoniae, are increasingly linked to severe bloodstream infections, with resistance exceeding 70% in some regions. Between 2018 and 2023, resistance rose in over 40% of monitored pathogen-anti…
Trust in Media at New Low of 28% in U.S.
Trust in U.S. news media has reached a historic low, with only 28% of adults expressing confidence in newspapers, television, and radio to report fully, fairly, and accurately. Confidence has declined across all partisan groups, with Republicans’ trust now in single digits (8%), independents at 27%, and Democrats holding a narrow majority (51%).
Generational divides are pronounced: adults 65…
2024–25 Flu Season Sees Record Pediatric Deaths: CDC Urges Vaccination
The 2024–25 influenza season saw the highest number of flu-associated pediatric deaths during a regular, non-pandemic season since national reporting began in 2004. As of September 13, 2025, 280 pediatric deaths were reported, with a median age of 7 years; over half had underlying medical conditions. Among those eligible and with known vaccination status, 89% were not fully vaccinated.
CDC em…
PHCC Offers New Graphics and Messaging for the 2025-26 Respiratory Illness Season
Public Health Communication Collaborative (PHCC) offers new social media graphics and messaging for public health communicators to support community preparation for the 2025–26 respiratory virus season, running November through April. Available in English and Spanish, these resources help explain respiratory virus prevention, updated vaccine eligibility, and the importance of COVID-19 and other vaccinations for both children and adults.
Step-by-step guides make it easy to encourage community members to find, schedule, and attend vaccine appointments. Early, clear communication can…
New Blood Test Detects HPV-Associated Head and Neck Cancer 10 Years Early
A new federally funded study demonstrates that a liquid biopsy called HPV-DeepSeek can detect HPV-associated head and neck cancers up to 10 years before symptoms appear. HPV causes roughly 70% of these cancers in the U.S., yet no screening test previously existed. Using whole-genome sequencing and machine learning, HPV-DeepSeek identifies microscopic fragments of HPV DNA in the blood with high sensitivity and specificity, potentially enabling earlier, less intensive treatment and improved outcomes.
Researchers are now validating these findings in a larger, blinded study. The work highligh…